首批公募业绩比较基准要素库正式发布。 继《公开募集证券投资基金业绩比较基准指引》《公开募集证券投资基金业绩比较基准操作细则》发布后，中国证券投资基金业协会（以下简称"中基协"）于近日 公布了公募基金业绩比较基准要素库，最新的业绩比较基准要素库共纳入155只指数，较此前征求意见稿中的141只增加了14只指数，公募基金业绩比较基准要素库 运作说明相比征求意见稿也有多处修订。 首批业绩比较基准要素库正式发布 1月23日，历经两个多月的公开征求意见，中国证监会与中国证券投资基金业协会同步正式出台《公开募集证券投资基金业绩比较基准指引》及《公开募集证券投 资基金业绩比较基准操作细则》，围绕公募基金业绩比较基准这一核心"锚点"与"标尺"的制度革新正式落地。 1月27日，中基协宣布，为落实《推动公募基金高质量发展行动方案》部署，规范公开募集证券投资基金业绩比较基准选取和使用，保护投资者的合法权益，根据 《证券投资基金法》《公开募集证券投资基金运作管理办法》《公开募集证券投资基金业绩比较基准指引》《公开募集证券投资基金业绩比较基准操作细则》及其 他有关法律法规，建立了公募基金业绩比较基准要素库。经第一届公募基金业绩比较基准要 ...

Core Points - The Tianjin Municipal Medical Insurance Bureau has issued the "Tianjin Basic Medical Insurance Medical Consumables Directory (2025)", which will be officially implemented on September 18, 2025 [1] - The directory aims to enhance the precision, scientific management, and standardization of medical consumables reimbursement under the medical insurance system, ensuring that insured patients receive their entitled benefits [1] Summary by Categories - **Reimbursement Scope**: The directory specifies the reimbursement range for medical consumables applicable to Tianjin's basic medical insurance and maternity insurance, currently including 3,062 types of medical consumables [1] - **Classification Management**: The consumables in the directory are categorized into two classes: Class A with 1,896 types and Class B with 1,166 types [1] - **Support for Innovation**: The directory supports technological innovation in the pharmaceutical industry and will implement dynamic adjustments with a "dynamic entry and exit" policy for consumables [1] - **Policy Clarity**: The compilation of the directory aims to clarify the range of consumables eligible for medical insurance payment, reasonably determine reimbursement standards, and gradually transition towards more refined management, aiding medical institutions in policy understanding and execution [1]